Drug General Information
Drug ID	D02ZPN
Former ID	DIB006616
Drug Name	NN-414
Synonyms	NNC-55-0414
Drug Type	Small molecular drug
Indication	Type 1 diabetes [ICD9: 250; ICD10:E10]		Phase 1	[521917]
Company	Novo Nordisk A/S
Structure		Download 2D MOL 3D MOL
Formula	C9H10ClN3O2S2
Canonical SMILES	S1(=O)(=O)c2c(cc(s2)Cl)NC(=N1)NC1(CC1)C
PubChem Compound ID	219048
Target and Pathway
Target(s)	Sulfonylurea receptor 1	Target Info	Modulator
KEGG Pathway	ABC transporters
	Insulin secretion
	Type II diabetes mellitus
Pathway Interaction Database	FOXA2 and FOXA3 transcription factor networks
PathWhiz Pathway	Muscle/Heart Contraction
	Pancreas Function
Reactome	ABC-family proteins mediated transport
	Regulation of insulin secretion
WikiPathways	Potassium Channels
	Integration of energy metabolism
References
Ref 521917	ClinicalTrials.gov (NCT00400283) A Study Looking Into the Effect of NNC 55-0414 in Subjects With Type 2 Diabetes. U.S. National Institutes of Health.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.